ANKENY, Iowa, Dec 01, 2009 (BUSINESS WIRE) -- Stuart Reeves, Ph.D., director of research and development, Embria Health Sciences, was recently elected to the board of directors of the Iowa Biotechnology Association. Embria manufactures and markets EpiCor, an innovative immune health ingredient used in nutritional products for the human health market.
"I look forward to serving on the board of directors for the Iowa Biotechnology Association," Dr. Reeves said. "It is my hope that my research experience on both the animal and human sides of the biotechnology industry will offer the board a unique perspective."
Dr. Reeves led the research and development efforts behind the development of Embria and its commercial launch in 2005. Prior to this, he acted as the primary senior scientist for Diamond V Mills, the world's leading supplier of fermented nutritional products. As such, Dr. Reeves laid the scientific foundation for many of the Diamond V research-based animal nutrition products.
About Embria Health Sciences:
Embria Health Sciences, www.embriahealth.com, combines science and nature to bring high-quality, research-based natural ingredients to the global human nutrition market. Embria's flagship ingredient, EpiCor, is an all-natural product designed to modulate and balance the human immune system and is manufactured using a proprietary technology which produces vital metabolites, vitamins, minerals, and antioxidants that deliver nutritional benefits. Recent human clinical studies show EpiCor significantly decreases the incidence of some common symptoms associated with seasonal allergies and decreases the incidence and duration of cold and flu symptoms. Different studies also show EpiCor possesses anti-inflammatory activity and activates crucial defense cells (Natural Killer, T-, and B-cells). Embria is based in Ankeny, Iowa.